药明康德公告,公司于2025年4月8日召开董事会审议通过2025年第二次以集中竞价交易方式回购A股股份的议案,并根据相关规定披露了前十大股东及前十大无限售条件股东的持股情况。其中,HKSCCNOMINEESLIMITED持股38702.45万股,占比13.40%,为第一大股东;香港中央结算有限公司持股23988.31万股,占比8.31%。本次公告还明确了公司总股本为288799.258万股。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.